Pfizer stayed quiet on drug that might fight Alzheimer’s

A team of Pfizer researchers made a startling find: The company’s blockbuster rheumatoid arthritis therapy Enbrel, a powerful anti-inflammatory drug, appeared to reduce the risk of Alzheimer’s disease. Image from video